Menopause causes profound changes to intimate tissue that are rarely discussed openly. Understanding what is happening — and what can genuinely help — makes an enormous difference to quality of life.
What Menopause Does to Intimate Tissue
The decline in oestrogen that accompanies perimenopause and menopause has direct and significant effects on the intimate tissues. Oestrogen plays a critical role in maintaining the health of the vaginal mucosa — stimulating the production of glycogen, which feeds the natural lactobacillus bacteria that maintain vaginal pH and moisture. As oestrogen falls, the mucosa thins, glycogen production decreases and natural lubrication diminishes.
The result is a constellation of symptoms collectively described as genitourinary syndrome of menopause (GSM): vaginal dryness, itching and burning; discomfort or pain during intercourse; increased susceptibility to urinary tract infections; and urinary urgency or leakage. These symptoms affect more than half of post-menopausal women and, unlike hot flushes, tend to worsen rather than improve over time without treatment.
Why GSM Is Underdiagnosed and Undertreated
Despite its prevalence and impact, GSM is significantly underdiagnosed. Many women do not raise these concerns with their doctors, either from embarrassment, a belief that they are an inevitable part of ageing, or simply not knowing that effective treatment exists. In Singapore's cultural context, intimate health remains a sensitive topic that many women suffer in silence.
Even when the condition is diagnosed, treatment options are often limited to topical oestrogen creams — which are effective but require ongoing daily application and are not suitable for all women. Energy-based technologies offer a non-hormonal alternative with durable results that do not depend on daily adherence.
How GLIFT Addresses Menopausal Vaginal Changes
GLIFT, performed exclusively by our Aesthetic Specialist at SkinRev Lab, delivers laser energy to the vaginal mucosa in a targeted, controlled manner. The thermal stimulus triggers a regenerative response in the mucosal tissue — stimulating collagen synthesis, restoring mucosal thickness, and reactivating the glycogen pathway that supports natural moisture and healthy vaginal flora.
Clinical evidence for vaginal laser treatments in the context of GSM shows meaningful improvement in dryness, discomfort during intercourse and vaginal pH in the majority of treated patients. Unlike topical hormonal treatments, the effects of each GLIFT session build cumulatively and are sustained over months after the treatment course concludes.
The Role of SKINGLIFT® in Menopausal Wellness
While GLIFT addresses the internal mucosal changes of menopause, SKINGLIFT® complements the protocol by addressing the structural and tonal changes that accompany oestrogen decline. The radiofrequency component remodels collagen in the vaginal walls and external tissue — improving tone and tightness. The pelvic floor EMS component addresses the urinary symptoms — urgency, frequency and leakage — that are a frequent and distressing feature of GSM.
Together, the GLIFT and SKINGLIFT® protocols represent a comprehensive approach to menopausal intimate wellness — addressing moisture, structure, tone, continence and sensation simultaneously, without hormones and without surgery.
"Menopause causes profound changes to intimate tissue that are rarely discussed openly. Understanding what is happening — and what …"
Frequently Asked Questions
Yes. The technologies used in GLIFT and SKINGLIFT® are specifically well-suited to the post-menopausal tissue environment. our clinical team will assess your individual situation and design a protocol appropriate for your current hormonal status and tissue condition.
Topical oestrogen restores mucosal health by directly supplying the hormone that is deficient. GLIFT achieves a similar outcome through a different mechanism — stimulating the tissue's own regenerative response — without introducing exogenous hormones. For women who cannot or prefer not to use hormonal treatments, GLIFT offers an effective alternative.
Most patients require two to three GLIFT sessions spaced four to six weeks apart for significant improvement in GSM symptoms. Maintenance sessions every twelve months help sustain the results. The protocol is personalised by our clinical team at consultation.
Yes. The pelvic floor EMS component of SKINGLIFT® directly addresses both urge and stress urinary incontinence — two of the most common and disruptive urinary symptoms of GSM. A course of three to six sessions typically produces measurable improvement in continence and urinary control.